Figshareopen access
Dual-ligand-modified cantharidin nanoparticles for the treatment of hepatocellular carcinoma via the inhibition of Ephb4
biochemistry, medicine, cell biology, pharmacology, biotechnology, cancer, biological sciences not elsewhere classified, chemical sciences not elsewhere classified
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 261766
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.